Bioinnovation has the potential to power your business ambition. And we are uniquely placed – with world-class expertise and facilities – to help deliver tangible, valuable commercial advantage.

We innovate at the exciting intersection of biology, engineering and advanced computation… to deliver breakthrough products and services with world-changing significance. Ours is a comprehensive approach founded on three core capabilities – Biostrategy, Biomeasurement and Biomanufacture. 

Biostrategy, Biomeasurement and Biomanufacture

Getting to market as the world transforms

Now more than ever, your route to market must navigate a complex, shifting global landscape. As risks arise, so do the potential rewards. Bioinnovation has the rare capacity to provide clarity and momentum in critical areas of opportunity, such as healthcare, agriculture and climate change. 

Ideas are the easier part; making them a reality is harder. The truth is, you require more than good technology to deliver positive change in a commercial context. To get to market, you need robust, realistic strategies. We can help you develop them because we understand the tools (biotechnology), the rules (governance models) and the interests (economic models) involved. Aligning all three is the secret to business success in Bioinnovation. 

Gaining insight with better information

Bioinnovation relies absolutely on Biomeasurement. It is the bedrock that enables control and optimization. But biological systems are extremely complex, span a huge scale range from km to nm and are incredibly difficult to measure. Success relies on seamless integration across numerous disciplines at which we are adept – including wetware, hardware and software. 

Our unique blend of abilities helps you bring new measurement and diagnosis products to market or integrate new measurement tools into your process and catalyze productivity gains. We understand and develop innovative sensors and cutting-edge data analysis. We’re able to bring together molecular biology, assay development, physics, electronics and AI to achieve the most complex measurements. And we package them for you in robust, easy-to-use, cost-effective solutions that comply with stringent regulatory requirements, including cGMP and medical device quality systems. 

Scaling up and delivering at viable cost

Researchers are continually discovering new ways to apply biology in their pursuit of breakthrough innovation. The real challenge is moving complex processes from the lab to high-volume manufacture at a cost that delivers business viability. Experience tells us that successful scale up demands optimization and invention across all disciplines – including biology, hardware, usability and control systems – plus rigorous regulatory compliance. 

We can help you optimize processes and develop the custom equipment you need to deliver at commercial cost and scale. We work seamlessly across biology, process optimization and equipment design to enable the successful manufacture and delivery of your product or advanced medical therapy. 

Talk to us about world-changing science

Our experience 

Proven in biodesign 

Our proven biodesign capability has grown organically from our long history in healthcare and life sciences. Few if any of our peers can match our holistic approach which adds biodesign to the complementary disciplines of engineering and computation. This unique breadth of expertise offers significant advantages that speed and ease your path to biomanufacture. 

Antha expertise 

Antha is a programming language for biology. It describes and executes complex workflows, driving massive productivity gains during biodesign. We are long-term partners with Synthace and use Antha in our labs. We can help you discover the power of Antha to unlock your science and gather the data you need without limits.    

Meet the core team

"Bioinnovation has the potential to reshape the global economy and transform every sector, in profound ways. Working here in Boston with our ambitious clients to realize their ideas and discoveries is tremendously rewarding." 
Mike Dunkley

"Biology knows no bounds and follows different rules to typical engineering tools and materials."
Ellen Simmons

"Providing unique solutions that take advantage of the breadth and depth of our collective knowledge is immensely fulfilling. I am very excited to be a part of our Boston-based bioinnovation team that expands our local and global expertise to include mammalian cell biology. This positions us to meet the diverse challenges our clients face in the ever-growing space where biological needs intersect with the computational and engineering arenas."
Karen Weisinger

“What excites me most is that bioinnovation will affect so many different industries – from the obvious ones like healthcare and agriculture to the more surprising like data storage and plastics.”  James Hallinan

"Our clients are diverse, the science they are trying to deliver is novel. Every project brings the opportunity to gain a new understanding." 
 Ian Taylor

Tech, tools & facilities



我们设在剑桥总部的微生物实验室使我们可以对微生物进行基因改造和特征描述。我们的设施达到了致病性菌株处理二级防护级别,我们的内部库令快速模块化 DNA 构建设计和组装成为可能。构建有机体,令其成为医疗保健和生物技术应用领域的生物传感器,是我们特别感兴趣的一个课题。



我们专门为在受控和管制的环境中处理和试验药物、受管制物质、生物危害物和人类样本而设计了一系列严格管理的 II 类实验室。我们的仪器室配备了计量、显微镜和产品测试设备,可以对原型和产品实施严格的验证和品控。 

Cell culture lab



Case studies


CATALOG DNA data encoding machine

2020年 05月 11日

Enabling the world's first DNA-based platform for massive data storage.

  • 生物创新

Better Origin insect larvae rearing

2017年 11月 25日

Harnessing the science of synthetic biology and best-in-class automation to turn organic waste into high-protein fish food.

  • 生物创新
  • 机械工程
  • 机器人

Biology-based contaminant monitoring

2017年 11月 23日

Developing biology-based sensors as a cost effective, long-term solution for monitoring environmental public health risks.

  • 生物创新
  • 工业设计
  • 产品开发
  • 传感技术

News & insights


Cambridge Consultants announces its collaboration with MedTech Innovator, a world-leading non-profit start-up accelerator

2021年 07月 13日

Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical devices.

  • 生物创新
  • 数字化医疗
  • 创新管理
  • 产品开发
  • 可持续性

Creating robust bioprocessing scale-down models

2021年 05月 18日

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

  • 生物创新

Flowfect™ Tx Revealed

2020年 10月 28日

Cambridge Consultants & Kytopen announce the initial release of the Flowfect™ Tx System, a breakthrough that will help deliver the full promise of cell therapies to tackle disease.

  • 生物创新

Building the business of biodesign

2018年 03月 27日

Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...

  • 生物创新
  • 创新管理
  • 产品开发
  • 战略咨询